Sept 24 (Reuters) – Biodesix Inc: * BIODESIX ADVANCES TWO COMPLEMENTARY APPROACHES TO MOLECULAR RESIDUAL DISEASE (MRD) MONITORING Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)